Historical Stock Price
ETFs Holding HZNP »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
05/20/2022 $90.00 $90.87 $87.88 $90.35 1.85M
05/23/2022 $90.04 $90.84 $87.00 $87.38 1.81M
05/24/2022 $87.44 $89.45 $87.12 $88.03 1.79M
05/25/2022 $87.78 $89.19 $87.18 $88.42 1.22M
05/26/2022 $88.42 $90.87 $88.36 $90.59 1.50M
Horizon Therapeutics is focused on researching, developing and commercializing medicines that address the needs for people with rare and rheumatic diseases. Co. has two segments, the orphan segment and the inflammation segment. The Orphan segment includes: TEPEZZA, which is indicated for the treatment of thyroid eye diseas; KRYSTEXXA, which is indicated for the treatment of uncontrolled gout; and PROCYSBI, which is indicated for nephropathic cystinosis. The Inflammation segment includes: PENNSAID 2% w/w, which is indicated for the treatment of pain of osteoarthritis (OA), of the knee(s); and DUEXIS, which is indicated for the relief of signs and symptoms of rheumatoid arthritis and OA.
HZNP historical stock prices picture
Horizon Therapeutics (HZNP) has the following price history information. Looking back at HZNP historical stock prices for the last five trading days, on May 20, 2022, HZNP opened at $90.00, traded as high as $90.87 and as low as $87.88, and closed at $90.35. Trading volume was a total of 1.85M shares. On May 23, 2022, HZNP opened at $90.04, traded as high as $90.84 and as low as $87.00, and closed at $87.38. Trading volume was a total of 1.81M shares. On May 24, 2022, HZNP opened at $87.44, traded as high as $89.45 and as low as $87.12, and closed at $88.03. Trading volume was a total of 1.79M shares. On May 25, 2022, HZNP opened at $87.78, traded as high as $89.19 and as low as $87.18, and closed at $88.42. Trading volume was a total of 1.22M shares. On May 26, 2022, HZNP opened at $88.42, traded as high as $90.87 and as low as $88.36, and closed at $90.59. Trading volume was a total of 1.50M shares.

HZNP Historical Stock Prices By Date:

HZNP historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Horizon Therapeutics shares, starting with a $10,000 purchase of HZNP, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/30/2012
End date: 05/26/2022
Start price/share: $3.89
End price/share: $90.59
Dividends collected/share: $0.00
Total return: 2,228.79%
Average Annual Total Return: 37.02%
Starting investment: $10,000.00
Ending investment: $232,857.45
Years: 9.99
Date Close
05/20/2022$90.35
05/23/2022$87.38
05/24/2022$88.03
05/25/2022$88.42
05/26/2022$90.59
HZNP is categorized under the Healthcare sector; below are some other companies in the same sector:

IART Historical Stock Prices
IAS Historical Stock Prices
IBIO Historical Stock Prices
ICAD Historical Stock Prices
ICCC Historical Stock Prices
ICEL Historical Stock Prices
ICLR Historical Stock Prices
ICO Historical Stock Prices
ICPT Historical Stock Prices
ICUI Historical Stock Prices

Also explore: HZNP shares outstanding history

Email EnvelopeFree HZNP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

HZNP Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.